GFR alpha-like产品信息
英文名称:GDNF family receptor alpha-like
靶点别称:GFR alpha like,GFR alpha-like,GFRAL,GRAL
物种:Human / Mouse / Cynomolgus / Rat
属性:Protein / Antibody Licensing
标记:Unconjugated
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>90% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.
GFR alpha-like分子背景
GFRα样也称为GDNF家族受体α样、GFRAL、C6orf144、UNQ9356、PRO34128。生长分化因子-15(GDF15)是一种循环蛋白,与多种生物学过程有关,包括能量稳态、体重调节和癌症和慢性病引起的恶病质。GDNF家族受体α样(GFRAL)最近被确定为负责介导GDF15厌食作用的神经元脑干受体。GDF15的脑干限制性受体,在代谢和毒素诱导的压力下调节食物摄入、能量消耗和体重。GDF15与其配体相互作用后,与RET相互作用,并通过激活MAPK和AKT信号通路诱导细胞信号传导。
关键字: GFR alpha like;GFR alpha蛋白;GFRAL;GFRAL蛋白;GRAL;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。